Research from Water Tower Research, Water Tower Research

Water Tower Research

Research from Water Tower Research

Water Tower Research is a leading equity research firm that provides research on micro, small and mid cap companies.

Water Tower Research was founded by Wall Street veterans after witnessing a fundamental shift in the investment research industry with the result being a declining knowledge base among investors, a lack of awareness and a shrinking pool of fundamental research being conducted on companies across the small-cap and micro-cap spectrum. The same issues are now increasingly occurring in the mid-cap space. This sea change within the investment community is impacting not only the companies themselves but also current shareholders and potential investors. With significantly less active sell-side sponsorship by Wall Street, a substantial information gap has developed between companies and various constituents in the financial community. The net result is fewer channels for insight and information to flow between companies and investors.

Equity Research Firm

Equity Bottom-Up

<div><ul><li>Meet the CEO. John Lai joined PetVivo to commercialize technology originating from Mayo Clinic studies funded by the Department of Defense.</li><li>While the company initially pursued human applications, Lai shifted focus to the FDA’s animal pathway as a faster route to market.</li><li>Lai built his career on identifying niche technologies he believed would gain broader adoption over a five- to 10-year horizon. </li></ul></div>

Meet the CEO. John Lai joined PetVivo to commercialize technology originating from Mayo Clinic studies funded by the Department of Defense.While the company initially pursued human applications, Lai shifted focus to the FDA’s animal pathway as a faster route to market.Lai built his career on identifying niche technologies he believed would gain broader adoption over a five- to 10-year horizon. 

WTR Healthcare Happenings Podcast Recap : PETV

United States

PetVivo Holdings, Inc. operates as a holding company. The Company, through its subsidiaries, develops, licenses, and distributes biotech and biomedical devices for the treatment of companion animals such as dogs and horses suffering from arthritis and other afflictions. PetVivo Holdings serves customers in the State of Minnesota.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00